A compact Urology Times: What's inside matters most

Article

The updated size is slightly smaller than our former traditional tabloid size, but little else has changed.

As you've likely noticed, this issue of Urology Times features a reduced, 9x12-inch publication size. Market research by publishing companies, including Advanstar Communications, the publisher of Urology Times, tells us that readers prefer a tighter, more compact format. We've listened to those requests. And we hope you find that the new size is more streamlined, easier to carry and reference, and more professional in appearance (not to mention more sturdy in the hands of a less-than-gentle U.S. Postal Service). The quarterly peer-reviewed Urology Times Clinical Edition will remain 8½ x 11 inches in size.

It's worth noting that how we define what's "inside" has undergone a significant transformation. A broad array of electronic offerings now complements our print content. Our 360° Network Guide provides a quick snapshot of these online offerings: news and updates, educational materials (including patient handouts and CME articles), podcasts, online tools (including financial calculators and patient forms), and community posts (including a blog by Neal Shore, MD, a Urology Times private practice board member). Each print article that has a tie-in to online content is flagged with a 360° Network icon for easy reference.

I welcome your comments about Urology Times' new size and our expanded multimedia offerings. Your input helps us to continuously improve and deliver the news and information that is most meaningful to you and your practice.

Related Videos
Kevin M. Wymer, MD
Video 7 - "Multidisciplinary Collaboration and Expert Insights in the Management of Advanced Prostate Cancer"
Video 6 - "Emerging AR Targeting Agents and CDK4/6 Inhibitors in Metastatic Prostate Cancer and Potential Impact on the Treatment Landscape"
Video 5 - "Targeting the Androgen Receptor Pathway and Overcoming Treatment Resistance in Advanced Prostate Cancer"
Video 4 - "Androgen Receptor Signaling and Its Role in Driving Prostate Cancer Metastasis"
Video 3 - "Treatment Selection in Metastatic and Castration Resistant Prostate Cancer: Optimizing Outcomes and Preserving Patient Quality of Life"
Video 2 - "Predicting Risk and Guiding Care: Biomarkers & Genetic Testing in Prostate Cancer"
Video 1 - "Metastatic Prostate Cancer: Background and Patient Prognosis"
Related Content
© 2024 MJH Life Sciences

All rights reserved.